{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:31:43Z","timestamp":1777984303998,"version":"3.51.4"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04786-4","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T18:04:27Z","timestamp":1771610667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sulfadiazine-induced crystalline nephropathy: a case report of a reversible cause of acute kidney injury in advanced HIV"],"prefix":"10.1186","volume":"27","author":[{"given":"Ziad","family":"Alahmadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Elena","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Hanouneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"12","key":"4786_CR1","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1016\/j.ekir.2021.09.003","volume":"6","author":"MA Perazella","year":"2021","unstructured":"Perazella MA, Herlitz LC. The crystalline nephropathies. Kidney Int Rep. 2021;6(12):2942\u201357.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"4786_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0002-9343(99)00041-8","volume":"106","author":"MA Perazella","year":"1999","unstructured":"Perazella MA. Crystal-induced acute renal failure. Am J Med. 1999;106(4):459\u201365.","journal-title":"Am J Med"},{"issue":"8","key":"4786_CR3","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2215\/CJN.11290821","volume":"17","author":"MA Perazella","year":"2022","unstructured":"Perazella MA. Drug-induced acute kidney injury: diverse mechanisms of tubular injury. Clin J Am Soc Nephrol. 2022;17(8):1220\u201333.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"4786_CR4","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2215\/CJN.00150118","volume":"13","author":"MA Perazella","year":"2018","unstructured":"Perazella MA. Pharmacology behind common drug nephrotoxicities. Clin J Am Soc Nephrol. 2018;13(12):1897\u2013908.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"4786_CR5","first-page":"1464","volume":"2","author":"S Kuppachi","year":"2021","unstructured":"Kuppachi S, Patel J, Jhaveri KD. AKI in a patient with cerebral toxoplasmosis. Kidney360. 2021;2(9):1464\u20137.","journal-title":"Kidney360"},{"issue":"6","key":"4786_CR6","first-page":"743","volume":"78","author":"CA Naughton","year":"2008","unstructured":"Naughton CA. Drug-induced nephrotoxicity. Am Fam Physician. 2008;78(6):743\u201350.","journal-title":"Am Fam Physician"},{"issue":"3","key":"4786_CR7","first-page":"239","volume":"6","author":"JTC Kwan","year":"1993","unstructured":"Kwan JTC, O\u2019Donnell PJ, O\u2019Donohoe J, Weston MJ. Sulfadiazine-induced crystalluria and renal failure in a patient with AIDS. J Am Board Fam Pract. 1993;6(3):239\u201342.","journal-title":"J Am Board Fam Pract"},{"issue":"4","key":"4786_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00005792-199607000-00002","volume":"1","author":"K Becker","year":"1996","unstructured":"Becker K, Jablonowski H, Dieter, H\u00e4ussinger. Sulfadiazine-Associated nephrotoxicity in patients with the acquired immunodeficiency syndrome. Medicine. 1996;1(4):185\u201394.","journal-title":"Medicine"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04786-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04786-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04786-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:05:46Z","timestamp":1774613146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04786-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4786"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04786-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7974324\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Mohamad Hanouneh reports serving on a speaker\u2019s bureau for Bayer, Novo Nordisk, Lilly and Boehringer Ingelheim. The remaining authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}